Go­ing glob­al, Take­da opens up 165,000-square-foot R&D fa­cil­i­ty in San Diego

Months af­ter con­sum­mat­ing its hefty $62 bil­lion deal to buy Ire­land’s Shire, Japan­ese drug­mak­er Take­da is strength­en­ing its roots in the Unit­ed States and en­rich­ing its glob­al re­search heft, by un­veil­ing a 165,000-square-foot fa­cil­i­ty in San Diego, Cal­i­for­nia, in ad­di­tion to its ex­ist­ing R&D cen­ter in Cam­bridge, Mass­a­chu­setts and plant in Shonan, Japan.

The new fa­cil­i­ty, an­nounced on Tues­day, will ex­tend Take­da’s $TAK 14-year pres­ence in San Diego, and is home to more than 250 em­ploy­ees fo­cused on R&D re­lat­ed to gas­troen­terol­o­gy and neu­ro­science.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.